<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.contemporarypediatrics.com/view/fda-approves-adrabetadex-for-infantile-onset-niemann-pick-type-c</loc>
      <lastmod>2026-11-17T19:55:19.466Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T19:55:19.466Z</news:publication_date>
        <news:title><![CDATA[FDA approves adrabetadex for infantile-onset Niemann-Pick type C]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/us-loses-measles-elimination-status-cdc-outlines-re-elimination-plan</loc>
      <lastmod>2026-11-17T19:40:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T19:40:00Z</news:publication_date>
        <news:title><![CDATA[US loses measles elimination status; CDC outlines re-elimination plan]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/insurers-denied-39-of-pediatric-allergy-asthma-biologic-requests</loc>
      <lastmod>2026-11-17T17:19:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T17:19:00Z</news:publication_date>
        <news:title><![CDATA[Insurers denied 39% of pediatric allergy, asthma biologic requests]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/maternal-deaths-fall-but-us-still-gets-d-on-preterm-birth</loc>
      <lastmod>2026-11-17T16:59:32.703Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T16:59:32.703Z</news:publication_date>
        <news:title><![CDATA[Maternal deaths fall, but US still gets D+ on preterm birth]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/tirzepatide-cuts-bmi-18-5-in-adolescents-with-obesity</loc>
      <lastmod>2026-11-16T21:10:01.475Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T21:10:01.475Z</news:publication_date>
        <news:title><![CDATA[Tirzepatide cuts BMI 18.5% in adolescents with obesity]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/maternal-autoantibodies-linked-to-autism-subtype-recurrence-risk</loc>
      <lastmod>2026-11-16T20:27:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:27:00Z</news:publication_date>
        <news:title><![CDATA[Maternal autoantibodies linked to autism subtype, recurrence risk]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/roflumilast-cream-0-05-eases-itch-improves-qol-in-infants-with-ad</loc>
      <lastmod>2026-11-16T20:20:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:20:00Z</news:publication_date>
        <news:title><![CDATA[Roflumilast cream 0.05% eases itch, improves QOL in infants with AD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/etavopivat-for-sickle-cell-disease-submitted-to-fda-and-ema</loc>
      <lastmod>2026-11-16T20:15:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:15:00Z</news:publication_date>
        <news:title><![CDATA[Etavopivat for sickle cell disease submitted to FDA and EMA]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/semaglutide-cuts-bmi-13-5-in-children-aged-6-to-11-with-obesity</loc>
      <lastmod>2026-11-16T20:06:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:06:00Z</news:publication_date>
        <news:title><![CDATA[Semaglutide cuts BMI 13.5% in children aged 6 to 11 with obesity]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.contemporarypediatrics.com/view/is-it-withdrawal-or-relapse</loc>
      <lastmod>2026-11-16T13:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Contemporary Pediatrics</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Is it withdrawal or relapse?]]></news:title>
      </news:news>
	</url></urlset>